StockWatch
·
Specialty Chemicals
Quarterly Result16 May 2026, 05:51 pm

Valiant Organics Approves Audited Financial Results for FY26

AI Summary

Valiant Organics Ltd's Board of Directors approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board also re-appointed Smt. Ketki D. Visariya as Cost Auditor and M/s. Manish Modi & Associates as Internal Auditor for FY 2026-27. Additionally, the Pharma Business was identified as an additional reportable segment.

Key Highlights

  • Audited standalone and consolidated financial results for FY26 approved.
  • Ketki D. Visariya re-appointed as Cost Auditor for FY 2026-27.
  • M/s. Manish Modi & Associates re-appointed as Internal Auditor for FY 2026-27.
  • Pharma Business identified as an additional reportable segment.